The National Institutes of Health are funding RIT scientists to explore vesicular stomatitis virus’s (VSV) potential for treating prostate cancer. Associate Professor Maureen Ferran from the Thomas H. Gosnell School of Life Sciences secured a three-year, $451,718 Research Enhancement Award (R15) grant from the NIH to investigate prostate cancer cells’ susceptibility to the virus.
The Washington Post talks to Jennifer Schneider, professor and Eugene H. Fram Chair of Applied Critical Thinking, and Maureen Ferran, associate professor in the Thomas H. Gosnell School of Life Sciences, about technology advances and COVID-19 tests.
The Conversation asks Maureen Ferran, associate professor in the Thomas H. Gosnell School of Life Sciences, about the Johnson & Johnson COVID-19 vaccine. This article was republished by PBS Newshour and the Houston Chronicle, among others.